MTOR anticorps (AA 1766-2144)
Aperçu rapide pour MTOR anticorps (AA 1766-2144) (ABIN2726554)
Antigène
Voir toutes MTOR (mTOR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1766-2144
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Human recombinant protein fragment corresponding to amino acids 1766-2144 of human MTOR(NP_004949) produced in E.coli.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- WB 1:2000, IHC 1:150,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Autre désignation
- MTOR
-
Poids moléculaire
- 288.7 kDa
-
NCBI Accession
- NM_004958
-
HGNC
- 2475
-
Pathways
- Signalisation PI3K-Akt, Signalisation RTK, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, L'effet Warburg
Antigène
-